• Home
  • News
  • Analysis
  •  
    Regions
    • Australasia
    • Southeast Asia
    • Greater China
    • North Asia
    • South Asia
    • North America
    • Europe
    • Central Asia
    • MENA
  •  
    Funds
    • LPs
    • Buyout
    • Growth
    • Venture
    • Renminbi
    • Secondary
    • Credit/Special Situations
    • Infrastructure
    • Real Estate
  •  
    Investments
    • Buyout
    • Growth
    • Early stage
    • PIPE
    • Credit
  •  
    Exits
    • IPO
    • Open market
    • Trade sale
    • Buyback
  •  
    Sectors
    • Consumer
    • Financials
    • Healthcare
    • Industrials
    • Infrastructure
    • Media
    • Technology
    • Real Estate
  • Events
  • Chinese edition
  • Data & Research
  • Weekly Digest
  • Newsletters
  • Sign in
  • Events
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)870 240 8859

      Email: customerservices@incisivemedia.com

      • Sign in
     
      • Saved articles
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • RSS
    • Twitter
    • LinkedIn
    • Newsletters
  • Free Trial
  • Subscribe
  • Weekly Digest
  • Chinese edition
  • Data & Research
    • Latest Data & Research
      2023-china-216x305
      Regional Reports

      The reports review the year's local private equity and venture capital activity and are filled with up-to-date data and intelligence on fundraising, investments, exits and M&A. The regional reports also feature information on key companies.

      Read more
      2016-pevc-cover
      Industry Review

      Asian Private Equity and Venture Capital Review provides an independent overview of the private equity, venture capital and M&A activities in the Asia region. It delivers insights on investments made, capital raised, sector specific figures and more.

      Read more
      AVCJ Database

      AVCJ Database is the ultimate link between Asian dealmakers and those who provide advisory, financial, legal and technological services to the private equity, venture capital and M&A industries. It is packed with facts and figures on more than 153,000 companies and almost 117,000 transactions.

      Read more
AVCJ
AVCJ
  • Home
  • News
  • Analysis
  • Regions
  • Funds
  • Investments
  • Exits
  • Sectors
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)870 240 8859

    Email: customerservices@incisivemedia.com

    • Sign in
 
    • Saved articles
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

China

Long Hill raises $300m for third China VC fund

Long Hill Capital closed its third US dollar-denominated fund at $300 million with a remit to pursue healthcare and longevity-related opportunities, which includes start-ups focused on wellness and services aimed at aging consumers.

  • Greater China
  • 08 April 2021
China grocery platform Dingdong Maicai raises $700m

DST Global and Coatue Management have led a $700 million Series D for China-based online fresh produce delivery business Dingdong Maicai. Existing investors including CMC Group re-upped.

  • Greater China
  • 08 April 2021
Qiming leads $30m Series B for China crypto start-up
Qiming leads $30m Series B for China crypto start-up

Qiming Venture Partners has led a $30 million Series B round for China-based imToken, which claims to be Asia’s largest crypto wallet.

  • Greater China
  • 06 April 2021
China's Source Code confirms $1b close on US dollar funds
China's Source Code confirms $1b close on US dollar funds

Source Code Capital has confirmed a final close of $1 billion on its latest set of US dollar-denominated funds, which takes the Chinese venture capital firm’s total assets under management to $2.5 billion.

  • Greater China
  • 06 April 2021
FountainVest, ClearVue back China self-driving truck player
FountainVest, ClearVue back China self-driving truck player

FountainVest Partners and ClearVue Partners have led a $220 million funding round for Plus, a China-based autonomous driving technology developer that specializes in trucks.

  • Greater China
  • 05 April 2021
B Capital expands into China, raises follow-on fund
B Capital expands into China, raises follow-on fund

US and Singapore-headquartered VC investor B Capital Group has established a China presence and closed a late-stage follow-on fund of $415 million for existing portfolio companies.

  • Greater China
  • 05 April 2021
Trustar to launch China growth strategy

Trustar Capital, a Chinese middle-market private equity firm until recently known as CITIC Capital, is complementing its flagship buyout strategy with a growth capital-oriented fund.

  • Greater China
  • 01 April 2021
Qingsong raises $153m for fourth China VC fund
Qingsong raises $153m for fourth China VC fund

Qingsong Fund, a Chinese venture capital firm formed by Xiaosong Liu, an angel investor and co-founder of Tencent Holdings, has closed its fourth renminbi-denominated fund with RMB1 billion ($153 million).

  • Greater China
  • 01 April 2021
Alibaba, DST lead Series D for China's Nice Tuan

Alibaba Group and DST Global have led a $750 million Series D round for Shihuituan, a China-based community group buying platform also known as Nice Tuan.

  • Greater China
  • 31 March 2021
China consumer brands Genki Forest, Tasogare secure funding
China consumer brands Genki Forest, Tasogare secure funding

Two emerging Chinese beverage brands - Genki Forest and Tasogare, which focus on sparkling water and coffee, respectively - have completed new funding rounds.

  • Greater China
  • 31 March 2021
MSPEA, Sihuan Pharma sell China hospital
MSPEA, Sihuan Pharma sell China hospital

Morgan Stanley Private Equity Asia (MSPEA) and Sihuan Pharmaceuticals have agreed to sell their 80% stake in China’s Huaiyin Hospital for RMB882.8 million ($134.3 million).

  • Healthcare
  • 31 March 2021
China chip designer Biren gets $410m Series B
China chip designer Biren gets $410m Series B

Biren Technology, a Chinese chip design company, has raised a RMB2.7 billion ($410 million) Series B round led by Ping An Insurance, New World Development, and Country Garden Venture Capital.

  • Greater China
  • 31 March 2021
Portfolio: GL Capital & SciClone Pharmaceuticals

GL Capital has helped China’s SciClone Pharmaceuticals position itself for the future while continuing to monetize its key legacy drug. A Hong Kong listing was the reward

  • Greater China
  • 30 March 2021
Matrix leads Series E tranche for China corporate training platform

Matrix Partners China has led a second tranche of Series E funding - worth $90 million - for Yunxuetang, a Chinese online corporate training services provider.

  • Expansion
  • 30 March 2021
Redpoint China promotes Kyle Liu to partner
Redpoint China promotes Kyle Liu to partner

Redpoint China Ventures has promoted Kyle Liu, who focuses on early-stage enterprise services and cutting-edge technology investments, to partner level.

  • Greater China
  • 30 March 2021
VMS leads $190m round for China CDMO player Chime
VMS leads $190m round for China CDMO player Chime

VMS Group, a Hong Kong-based asset manager, has led a $190 million extended Series A round of funding for Chime Biologics, a Chinese contract development and manufacturing organization (CDMO).

  • Greater China
  • 30 March 2021
Wise Road agrees $1.4b take-private of Korea chipmaker
Wise Road agrees $1.4b take-private of Korea chipmaker

Wise Road Capital, a China-based private equity firm that focuses on high-tech investments, has agreed to privatize Korea’s Magnachip Semiconductor Corporation at a valuation of $1.4 billion.

  • Greater China
  • 30 March 2021
KKR joins $200m round for China coding education start-up

Hetao 101, a Chinese online education platform that provides computer programming courses for children, has raised $200 million in Series C funding led by KKR, Vision Plus Capital, and GL Ventures.

  • Greater China
  • 29 March 2021
China's Baidu raises funding for chip unit at $2b valuation
China's Baidu raises funding for chip unit at $2b valuation

CPE has led a funding round for Kunlun, the semiconductor unit of Chinese search giant Baidu, at a post-deal valuation of approximately RMB13 billion ($2 billion).

  • Greater China
  • 29 March 2021
China's Zhihu completes $522m IPO, endures volatile debut
China's Zhihu completes $522m IPO, endures volatile debut

Chinese question-and-answer platform Zhihu endured a difficult New York Stock Exchange debut, closing at a 10.5% discount to its IPO price on a day when US-listed Chinese stocks fluctuated wildly.

  • Greater China
  • 28 March 2021
PE topples advisory as China Renaissance's key business

Fund management has become China Renaissance’s largest source of revenue, seven years after the firm – best known for providing private placement and M&A advisory services to Chinese internet companies – entered the private equity business.

  • Greater China
  • 28 March 2021
China yogurt brand secures $122m Series B
China yogurt brand secures $122m Series B

Simple Love, also known as Jian’Ai, a Chinese yogurt brand, has raised RMB800 million ($122 million) in Series B funding from Matrix Partners China, BA Capital, CITIC Agriculture Fund, and Maison Capital. They all backed the company's RMB400 million Series...

  • Greater China
  • 26 March 2021
China autonomous driving start-up TuSimple files for US IPO
China autonomous driving start-up TuSimple files for US IPO

TuSimple, a China and US-based developer of autonomous driving technology for trucks, has filed for a US IPO. Its backers include CDH Investments, Zhiping Capital, Sina Corporation, and Hong Kong hedge fund Composite Capital.

  • Greater China
  • 26 March 2021
Hony launches China healthcare, consumer SPAC
Hony launches China healthcare, consumer SPAC

Hony Capital has joined a string of Chinese private equity managers with special purpose acquisition vehicles (SPACs), targeting $300 million for healthcare and consumer deals.

  • Greater China
  • 26 March 2021
474849
  • About AVCJ
  • Advertise
  • Contacts
  • About ION Analytics
  • Terms of use
  • Privacy policy
  • Group disclaimer
  • RSS
  • Twitter
  • LinkedIn
  • Newsletters

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013